Page last updated: 2024-10-20

uric acid and Glycogen Storage Disease Type V

uric acid has been researched along with Glycogen Storage Disease Type V in 11 studies

Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.

Glycogen Storage Disease Type V: Glycogenosis due to muscle phosphorylase deficiency. Characterized by painful cramps following sustained exercise.

Research Excerpts

ExcerptRelevanceReference
"We report the first case of McArdle's disease (muscle phosphorylase deficiency) and tophaceous gout."1.28McArdle's disease and gout. ( de Miguel, E; Espinosa, A; Gijón, J; Mateos, FA; Miranda, E; Puig, JG; Romera, NM, 1992)

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19906 (54.55)18.7374
1990's2 (18.18)18.2507
2000's1 (9.09)29.6817
2010's2 (18.18)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Üsküdar Cansu, D1
Erdoğan, B1
Korkmaz, C1
Kitaoka, Y1
Ogborn, DI1
Nilsson, MI1
Mocellin, NJ1
MacNeil, LG1
Tarnopolsky, MA1
Yamasaki, T1
Mineo, I5
Jinnai, K1
Kono, N5
Yamamoto, Y1
Kanda, F1
Ohno, S1
Tsutsumi, M1
Yamada, Y4
Kawachi, M3
Tarui, S4
Fujita, T1
Puig, JG1
de Miguel, E1
Mateos, FA1
Miranda, E1
Romera, NM1
Espinosa, A1
Gijón, J1
Hara, N3
Kiyokawa, H2
Nakajima, H2
Shimizu, T3
Kuwajima, M1
Wang, YL2
Hardiman, O1
Farrell, M1
McElvaney, G1
Tipton, K1
Staunton, H1
Fox, IH1
Sumi, S1
Nonaka, K1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
GDF-15 as a Biomarker for Mitochondrial Disease[NCT02745938]97 participants (Actual)Observational2016-06-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

2 reviews available for uric acid and Glycogen Storage Disease Type V

ArticleYear
Can hyperuricemia predict glycogen storage disease (McArdle's disease) in rheumatology practice? (Myogenic hyperuricemia).
    Clinical rheumatology, 2019, Volume: 38, Issue:10

    Topics: Adult; Antirheumatic Agents; Arthritis; Arthritis, Gouty; Diagnosis, Differential; Diagnostic Errors

2019
[Secondary hyperuricemia in glycogen storage disease types I, III, V and VII].
    Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61 Suppl 1

    Topics: Glycogen Storage Disease Type I; Glycogen Storage Disease Type III; Glycogen Storage Disease Type V;

2003

Other Studies

9 other studies available for uric acid and Glycogen Storage Disease Type V

ArticleYear
Oxidative stress and Nrf2 signaling in McArdle disease.
    Molecular genetics and metabolism, 2013, Volume: 110, Issue:3

    Topics: Aldehydes; Female; Gene Expression Regulation; Glucosyltransferases; Glycogen Storage Disease Type V

2013
Glycogenosis type V (McArdle's disease) with hyperuricemia. A case report and clinical investigation.
    European neurology, 1993, Volume: 33, Issue:3

    Topics: Adult; Biopsy; Enzymes; Exercise Test; Glycogen Storage Disease Type V; Gout; Humans; Male; Muscles;

1993
McArdle's disease and gout.
    Muscle & nerve, 1992, Volume: 15, Issue:7

    Topics: Adenine Nucleotides; Arthritis, Gouty; Exercise Test; Glycogen Storage Disease Type V; Humans; Male;

1992
Myogenic hyperuricemia: a comparative study between type V and type VII glycogenosis.
    Advances in experimental medicine and biology, 1989, Volume: 253A

    Topics: Adolescent; Adult; Exercise; Female; Glycogen Storage Disease; Glycogen Storage Disease Type V; Glyc

1989
[Glycogenosis (molecular mechanism of muscle glycogenosis)].
    Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme, 1988, Volume: 33, Issue:5

    Topics: Adenosine Triphosphate; Amino Acid Sequence; Glycogen; Glycogen Storage Disease; Glycogen Storage Di

1988
Hyperuricemia in type V glycogenosis.
    Neurology, 1987, Volume: 37, Issue:4

    Topics: Glycogen Storage Disease; Glycogen Storage Disease Type V; Humans; Male; Middle Aged; Muscles; Physi

1987
Myogenic hyperuricemia. A common pathophysiologic feature of glycogenosis types III, V, and VII.
    The New England journal of medicine, 1987, Jul-09, Volume: 317, Issue:2

    Topics: Adult; Ammonia; Glycogen Storage Disease; Glycogen Storage Disease Type III; Glycogen Storage Diseas

1987
Adenosine triphosphate degradation in specific disease.
    The Journal of laboratory and clinical medicine, 1985, Volume: 106, Issue:2

    Topics: Adenine; Adenosine Triphosphate; Biotransformation; Carnitine O-Palmitoyltransferase; Ethanol; Fruct

1985
Excess purine degradation in exercising muscles of patients with glycogen storage disease types V and VII.
    The Journal of clinical investigation, 1985, Volume: 76, Issue:2

    Topics: Adult; Ammonia; Female; Glycogen Storage Disease; Glycogen Storage Disease Type V; Glycogen Storage

1985